Enhabit Inc (EHAB) Stock Price, Quote & News

Company Profile

Enhabit, Inc. provides home health and hospice services in the United States. The Home Health segment offers nursing care; physical, occupational, and speech therapy; medical and social work; and home health aide services. This segment also provides patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, includi...

Industry: Medical Care Facilities

Sector: Healthcare

Phone: 214 239 6500

Website: www.ehab.com

Address:

6688 North Central Expressway, Suite 1300, Dallas, United States

Mergerbrief May. 12 at 11:54 AM

$EHAB / Kinderhook Industries – Shareholder Vote EHAB

0 · Reply

OfficialStocktwitsUser May. 11 at 9:09 PM

$EHAB RSI: 75.00, MACD: 0.0367 Vol: 0.05, MA20: 13.75, MA50: 13.75 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

StocktwitsEarnings May. 7 at 8:35 PM

$EHAB Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.37 up 5.71% YoY • Reported revenue of $264.8M up 1.89% YoY • Enhabit Inc expects a 2.4% estimated net increase to hospice payments for fiscal year 2027, effective October 1, 2026, and anticipates spending approximately $5M for maintenance capital expenditures during 2026.

0 · Reply

SuperGreenToday Apr. 28 at 6:12 AM

$EHAB Share Price: $13.75 Contract Selected: Oct 16, 2026 $10 Calls Buy Zone: $3.06 – $3.78 Target Zone: $5.32 – $6.50 Potential Upside: 64% ROI Time to Expiration: 171 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

briefingcom Apr. 17 at 12:45 PM

$EHAB: Enhabit Inc. sets stockholder meeting date of May 12, 2026, to approve transaction with Kinderhook; expected to close in the second quarter of 2026 https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20260417062751EHAB&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

0 · Reply

Mottdahopple Mar. 30 at 2:42 PM

$EHAB why is this trading highertoday? beyond merger price?

0 · Reply

Mergerbrief Mar. 20 at 12:16 PM

$EHAB / Kinderhook Industries – HSR File By Date

0 · Reply

StocktwitsEarnings Mar. 5 at 1:00 AM

$EHAB Q4 '25 Earnings Results & Recap Enhabit reported total net service revenue of $270.4M and consolidated Adjusted EBITDA grew 11.6% year over year to $28M, with Adjusted diluted EPS of $0.14.

0 · Reply

Investor6 Mar. 3 at 8:09 PM

$EHAB less than 2% from the definitive agreement price, no reason to hold more. Better consider other arbitrage plays, a safe place to be nowadays.

0 · Reply

Joby099 Feb. 24 at 10:41 AM

$VNDA $ACLX $GETY $EHAB

0 · Reply

Enhabit Sets Stockholder Meeting Date of May 12, 2026, to Approve Transaction with Kinderhook

2026-03-05T23:45:14.000Z - 2 months ago

Enhabit downgraded to Hold from Buy at TD Cowen

2026-03-04T21:24:19.000Z - 2 months ago

Enhabit reports Q4 EPS 14c, consensus 14c

Mar 4, 2026, 4:10 PM EST - 2 months ago

Enhabit Reports Fourth Quarter 2025 Financial Results

Feb 24, 2026, 10:28 AM EST - 2 months ago

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Enhabit, Inc. (EHAB)

2026-02-24T01:15:16.000Z - 2 months ago

Enhabit downgraded to Neutral from Buy at UBS

2026-02-23T18:37:02.000Z - 2 months ago

Enhabit downgraded to Hold from Buy at Jefferies

2026-02-23T15:31:45.000Z - 2 months ago

Enhabit price target raised to $13.80 from $9.50 at Leerink

2026-02-23T15:25:53.000Z - 2 months ago

Enhabit price target raised to $13.80 from $10.50 at Truist

2026-02-23T15:06:45.000Z - 2 months ago

Enhabit downgraded to Perform from Outperform at Oppenheimer

2026-02-23T13:32:33.000Z - 2 months ago

Enhabit to be acquired by Kinderhook Industries for $13.80 per share in cash

Feb 23, 2026, 8:00 AM EST - 2 months ago

Enhabit to be Acquired by Kinderhook Industries

Feb 12, 2026, 4:15 PM EST - 3 months ago

Enhabit Home Health & Hospice Announces Date of 2025 Fourth Quarter Earnings Call

2026-02-12T14:25:47.000Z - 3 months ago

Enhabit, Encompass Health collect $43.1M from individual defendants

EHC

Feb 12, 2026, 7:30 AM EST - 3 months ago

Enhabit and Encompass Health Collect $43.1 Million from Individual Defendants in Delaware Fiduciary Breach Case

EHC

2026-01-22T13:16:17.000Z - 3 months ago

Oppenheimer upgrades Enhabit on better reimbursement outlook

2026-01-22T11:50:42.000Z - 3 months ago

Enhabit upgraded to Outperform from Perform at Oppenheimer

2026-01-13T10:40:47.000Z - 4 months ago

Enhabit upgraded to Buy from Hold at TD Cowen

2026-01-08T10:30:29.000Z - 4 months ago

Enhabit upgraded to Buy from Neutral at UBS

2026-01-07T12:12:34.000Z - 4 months ago

Enhabit initiated with a Hold at Truist

2025-12-16T13:40:18.000Z - 5 months ago

Enhabit price target raised to $12 from $11 at Jefferies

Dec 9, 2025, 3:50 PM EST - 5 months ago

Enhabit Transcript: Bank of America Home Care Conference

Dec 2, 2025, 4:15 PM EST - 5 months ago

Enhabit Announces Participation in Bank of America Home Care Conference 2025

Nov 11, 2025, 12:30 PM EST - 6 months ago

Enhabit Transcript: UBS Global Healthcare Conference 2025

Nov 6, 2025, 9:00 AM EST - 6 months ago

Enhabit Earnings Call Transcript: Q3 2025

2025-11-05T22:10:17.000Z - 6 months ago

Enhabit reports Q3 EPS 17c, consensus 12c

Nov 5, 2025, 4:13 PM EST - 6 months ago

Enhabit Reports Third Quarter 2025 Financial Results

Oct 28, 2025, 4:15 PM EDT - 7 months ago

Enhabit Announces Participation in UBS Global Healthcare Conference 2025

Oct 16, 2025, 4:15 PM EDT - 7 months ago

Enhabit Home Health & Hospice Announces Date of 2025 Third Quarter Earnings Call

Sep 30, 2025, 11:55 AM EDT - 8 months ago

Enhabit Transcript: Jefferies 2025 Healthcare Services Conference

Sep 16, 2025, 4:15 PM EDT - 8 months ago

Enhabit Announces Participation in Jefferies 2025 Healthcare Services Conference

2025-08-08T11:41:06.000Z - 9 months ago

Enhabit price target lowered to $8.50 from $10 at UBS

Aug 7, 2025, 10:00 AM EDT - 9 months ago

Enhabit Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:16 PM EDT - 9 months ago

Enhabit Home Health & Hospice Announces CEO Transition Plan

Aug 6, 2025, 4:15 PM EDT - 9 months ago

Enhabit Reports Second Quarter 2025 Financial Results

Jul 17, 2025, 4:15 PM EDT - 10 months ago

Enhabit Home Health & Hospice Announces Date of 2025 Second Quarter Earnings Call

Jun 10, 2025, 10:00 AM EDT - 1 year ago

Enhabit Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

May 20, 2025, 4:10 PM EDT - 1 year ago

Enhabit Announces Participation in Goldman Sachs 46th Annual Global Healthcare Conference

May 8, 2025, 10:00 AM EDT - 1 year ago

Enhabit Earnings Call Transcript: Q1 2025

May 7, 2025, 4:15 PM EDT - 1 year ago

Enhabit Reports First Quarter 2025 Financial Results

Apr 17, 2025, 4:12 PM EDT - 1 year ago

Enhabit Home Health & Hospice Announces Date of 2025 First Quarter Earnings Call

Mar 11, 2025, 4:15 PM EDT - 1 year ago

Enhabit Home Health & Hospice Achieves Level 2 Recognition as an Age-Friendly Health System — Committed to Care Excellence

Mar 6, 2025, 10:00 AM EST - 1 year ago

Enhabit Earnings Call Transcript: Q4 2024

Mar 5, 2025, 4:16 PM EST - 1 year ago

Enhabit Reports Fourth Quarter Results and Issues Full-Year 2025 Guidance

Feb 25, 2025, 4:15 PM EST - 1 year ago

Enhabit Home Health & Hospice to Nominate Stephan Rodgers to Board of Directors

Feb 13, 2025, 4:15 PM EST - 1 year ago

Enhabit Home Health & Hospice Announces Date of 2024 Fourth Quarter Earnings Call

Jan 30, 2025, 5:05 PM EST - 1 year ago

Enhabit Home Health & Hospice Earns 2025 Great Place To Work Certification™

Dec 10, 2024, 9:00 AM EST - 1 year ago

Enhabit Transcript: Bank of America Home Care Conference

Dec 4, 2024, 8:30 AM EST - 1 year ago

Delaware Court of Chancery Awards Damages and Other Relief to Encompass Health and Enhabit for Misconduct by April Anthony, Other Former Officers, and Private Equity Firms Vistria Group and Nautic Partners

EHC

Nov 19, 2024, 4:17 PM EST - 1 year ago

Enhabit Announces Participation in Upcoming BofA Home Care Conference

Nov 7, 2024, 10:00 AM EST - 1 year ago

Enhabit Earnings Call Transcript: Q3 2024

Nov 7, 2024, 7:30 AM EST - 1 year ago

Enhabit Home Health & Hospice Appoints Ryan Solomon as Chief Financial Officer

Nov 6, 2024, 4:19 PM EST - 1 year ago

Enhabit Reports Third Quarter 2024 Financial Results

Oct 17, 2024, 4:35 PM EDT - 1 year ago

Enhabit Home Health & Hospice Recognized as an Age-Friendly Health Systems Participant

Oct 8, 2024, 4:10 PM EDT - 1 year ago

Enhabit Home Health & Hospice Announces Date of 2024 Third Quarter Earnings Call

Oct 4, 2024, 4:04 PM EDT - 1 year ago

Vanguard Group Inc's Strategic Reduction in Enhabit Inc Shares

Sep 6, 2024, 6:43 PM EDT - 1 year ago

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

ADNT BIO CHCT CMP CNH DBI DDD

Sep 5, 2024, 11:00 AM EDT - 1 year ago

Enhabit Transcript: 2024 Wells Fargo Healthcare Conference

Aug 21, 2024, 4:10 PM EDT - 1 year ago

Enhabit Announces Participation in Upcoming Investor Conferences

Aug 7, 2024, 10:00 AM EDT - 1 year ago

Enhabit Earnings Call Transcript: Q2 2024

Aug 6, 2024, 4:40 PM EDT - 1 year ago

Enhabit Announces CFO Transition

Aug 6, 2024, 4:10 PM EDT - 1 year ago

Enhabit Reports Second Quarter 2024 Financial Results

Jul 29, 2024, 9:00 AM EDT - 1 year ago

AREX Capital Announces Director Appointment to Enhabit Board

Jul 25, 2024, 11:00 AM EDT - 1 year ago

Enhabit Announces Preliminary Results of 2024 Annual Meeting of Stockholders

Jul 22, 2024, 9:00 AM EDT - 1 year ago

AREX Capital Urges Fellow Stockholders to Support Meaningful Change at Enhabit at the Upcoming Annual Meeting

Jul 22, 2024, 7:45 AM EDT - 1 year ago

Enhabit Urges Stockholders to Protect the Value of their Investment by Voting FOR Enhabit's Nominees at the July 25 Annual Meeting

Jul 18, 2024, 9:55 AM EDT - 1 year ago

Glass Lewis Recommends Stockholders Support Significant Change at Enhabit by Voting the WHITE Proxy Card “FOR” Three of AREX Capital's Nominees

Jul 15, 2024, 7:45 AM EDT - 1 year ago

Enhabit Releases Certain Preliminary Second Quarter 2024 Results

Jul 12, 2024, 9:00 AM EDT - 1 year ago

ISS Recommends Stockholders Support Meaningful Change at Enhabit by Voting the WHITE Proxy Card “FOR” Three of AREX Capital's Nominees

Jul 12, 2024, 6:00 AM EDT - 1 year ago

ISS Recommends Stockholders Vote “FOR” a Majority of Enhabit Home Health & Hospice Director Nominees

Jul 9, 2024, 4:10 PM EDT - 2 years ago

Enhabit Home Health & Hospice Announces Date of 2024 Second Quarter Earnings Call

Jul 8, 2024, 7:45 AM EDT - 2 years ago

Enhabit Reiterates That its Current Board is Best Positioned to Deliver Enhanced Value in Letter to Stockholders

Jul 5, 2024, 9:20 AM EDT - 2 years ago

AREX Capital Expresses Disappointment in Enhabit's Continued Excuses and Empty Promises

Jul 1, 2024, 4:15 PM EDT - 2 years ago

Enhabit Releases Investor Presentation Demonstrating Execution of Clear Growth Strategy and Path to Unlock Shareholder Value

Jun 27, 2024, 4:15 PM EDT - 2 years ago

AREX Capital Releases Presentation Detailing Its Nominees' Comprehensive Plan to Deliver Enduring Value for Enhabit Stockholders

Jun 24, 2024, 7:45 AM EDT - 2 years ago

Enhabit Demonstrates Progress to Stabilize Business and Position Company for Profitable Growth

Mergerbrief May. 12 at 11:54 AM

$EHAB / Kinderhook Industries – Shareholder Vote EHAB

0 · Reply

OfficialStocktwitsUser May. 11 at 9:09 PM

0 · Reply

StocktwitsEarnings May. 7 at 8:35 PM

0 · Reply

SuperGreenToday Apr. 28 at 6:12 AM

0 · Reply

briefingcom Apr. 17 at 12:45 PM

0 · Reply

Mottdahopple Mar. 30 at 2:42 PM

$EHAB why is this trading highertoday? beyond merger price?

0 · Reply

Mergerbrief Mar. 20 at 12:16 PM

$EHAB / Kinderhook Industries – HSR File By Date

0 · Reply

StocktwitsEarnings Mar. 5 at 1:00 AM

$EHAB Q4 '25 Earnings Results & Recap Enhabit reported total net service revenue of $270.4M and consolidated Adjusted EBITDA grew 11.6% year over year to $28M, with Adjusted diluted EPS of $0.14.

0 · Reply

Investor6 Mar. 3 at 8:09 PM

$EHAB less than 2% from the definitive agreement price, no reason to hold more. Better consider other arbitrage plays, a safe place to be nowadays.

0 · Reply

Joby099 Feb. 24 at 10:41 AM

$VNDA $ACLX $GETY $EHAB

0 · Reply

AcceleratorModel Feb. 24 at 5:35 AM

$EHAB damn — Watched this and didn’t do anything about it

0 · Reply

Joby099 Feb. 23 at 9:54 PM

$VNDA $ACLX $GETY $EHAB

0 · Reply

StockJelli Feb. 23 at 8:55 PM

Here are the stocks towards the end of power hour: $ACLX $VNDA $EHAB $VOR $VRE

0 · Reply

StockJelli Feb. 23 at 6:27 PM

Market is down today, but still some green stocks. Remember, we only count stocks with at least $100 million market cap. $ACLX $VNDA $EHAB $VRE $NAMM

0 · Reply

RunnerSignals Feb. 23 at 6:22 PM

$ACLX $EHAB $NEWP $IBRX $OIS shows accumulation into highs while consensus waits for pullbacks https://stocksrunner.com/stock-market-sentiment

0 · Reply

Joby099 Feb. 23 at 6:07 PM

$VNDA $ACLX $GETY $EHAB Great Call!!

0 · Reply

topstockalerts Feb. 23 at 5:41 PM

$EHAB healthcare services Behavioral health operator tied to reimbursement rates and occupancy levels. Earnings and guidance revisions drive re rate. Any state level contract win is material. Does margin inflect this year?

0 · Reply

StockJelli Feb. 23 at 5:12 PM

Ok here are the current stocks that have momentum. Be sure to check the live screener. $ACLX $VNDA $VHUB $EHAB $SLS

0 · Reply

StockJelli Feb. 23 at 3:16 PM

Good morning. Here are the momentum stocks this morning. $ACLX $VNDA $IBRX $EHAB $IKT

0 · Reply

Joby099 Feb. 23 at 2:28 PM

$VNDA $ACLX $GETY $EHAB His levels actually make sense when price hits them. 🤝📈 https://www.youtube.com/watch?v=-6C5h3I3fQs

0 · Reply

Market Cap	705.89M
Revenue (ttm)	1.06B
Net Income (ttm)	-4.60M
EPS (ttm)	N/A
PE Ratio	25.54
Forward PE	25.54
Profit Margin	-0.43%
Debt to Equity Ratio	0.74

Volume	3,401,700
Avg Vol	1,181,408
Day's Range	N/A - N/A
Shares Out	51.23M
Stochastic %K	83%
Beta	1.26
Analysts	Hold
Price Target	$13.80